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Rapid growth of previously dormant metastases following surgical
removal of a primary tumour is well documented (Arai et al, 1992;
Kodama et al, 1992). Up to 50% of patients diagnosed with
primary cancer already have metastatic deposits (Fidler and Ellis,
1994). The mechanisms controlling growth and dormancy of
metastases is an area of intense investigation. Primary tumours
have been shown to inhibit the growth of their own metastases by
the secretion of angiogenesis inhibitors such as angiostatin and
endostatin (O’Reilly et al, 1994; O’Reilly et al, 1997). Tumour
manipulation during surgery may increase tumour cell dissemina-
tion into the bloodstream resulting in the seeding of tumour cells
in distant organs and the establishment of metastases (Hansen et
al, 1995). Surgical removal of a primary tumour may therefore not
only facilitate the seeding of metastases, but also create a permis-
sive environment for their subsequent growth by removing the
source of angiogenesis inhibitors. We have previously reported
that the growth of metastases following excision of a B16
melanoma primary tumour was increased when a simultaneous
laparotomy or laparoscopy was performed at the time of excision
(Da Costa et al, 1998). The effect of the surgical insult itself on the
growth of metastases therefore merits separate investigation.
Tumour cell metastasis is a complex multistep process
involving a number of cell types, cytokines and pathways
(Crissman et al, 1988; Naylor and Balkwill, 1995). Angiogenesis,
the formation of new blood vessels, is essential for the growth of
primary tumours and established metastases (Folkman, 1990;
Fidler and Ellis, 1994). In the absence of neovascularization, solid
tumours are restricted to a diameter of 2–3 mm3 (Folkman, 1990).
New vessel formation is associated with increased metastasis as
the new vessels allow tumour cells access to the circulation
(Weidner et al, 1991; Anan et al, 1996). Net angiogenesis is a
consequence of the balance between pro- and anti-angiogenic
molecules. Vascular endothelial growth factor (VEGF), also
known as vascular permeability factor (VPF), is a potent angio-
genic cytokine stimulating the growth and differentiation of
endothelial cells (Peters et al, 1993). It also increases vascular
permeability resulting in leaky blood vessels thereby facilitating
tumour cell extravasation, a critical step in the metastatic cascade
(Clauss et al, 1990; Marmé, 1996). VEGF is produced by a variety
of host inflammatory and tumour cells (Sunderkotter et al, 1994;
Freeman et al, 1995; Harmey et al, 1998).
In addition to new vessel formation, net tumour growth depends
on the balance between tumour cell proliferation and apoptosis
(Holmgren et al, 1995). Apoptosis, or programmed cell death, is
characterized by single-cell death in the midst of living cells.
When proliferation equals the rate of apoptosis, no net growth
results and the tumours enter a state of quiescence or dormancy.
Endotoxin or lipopolysaccharide (LPS) is a cell wall constituent
of Gram-negative bacteria that is present ubiquitously in the
atmosphere at concentrations of approximately 1 mg m–3 (Rylander
et al, 1989). Another major source of endotoxin is endogenous gut
bacteria. Abdominal contamination with airborne factors during
surgery has previously been shown to cause immunological
alterations and bacterial translocation (Watson et al, 1995). Recent
reports have shown that endotoxin is angiogenic, inducing neovas-
cularization in both the mesenteric window and corneal implant
model (Li et al, 1991; Mattsby-Baltzer et al, 1994; Kenyon et al,
1996).
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increased metastatic tumour growth and that this increase is due,
at least in part, to LPS introduced during the surgical procedure
and/or LPS translocation within the peritoneal cavity. To investi-
gate the role of surgery and endotoxin in metastatic growth we
used a murine model of metastatic disease where no primary
tumour is established. In this model, alterations in tumour growth
cannot be attributed to the removal of angiogenesis inhibitors,
such as angiostatin, derived from primary tumours. We assessed
the effects of laparotomy, air laparoscopy, laparoscopy with air
exclusion under carbon dioxide (CO2) and endotoxin injection
(10 mg per animal) on metastatic tumour burden. Increased
metastatic burden, elevated serum VEGF, elevated circulating
LPS, increased tumour cell proliferation and decreased apoptosis
were identified in animals subjected to laparotomy or air
laparoscopy. In the CO2 laparoscopy group, these parameters were
similar to controls. In animals receiving endotoxin injection,
metastatic growth was similar to that observed in the laparotomy
group.
MATERIALS AND METHODS
Animals
Male 6- to 8-week old BALB/c mice (Charles River Institute,
Margate, Kent, UK) were used. The animals were acclimatized for
1 week and caged in groups of five or less in an air-conditioned
room at ambient temperature of 21–22°C and 50% relative
humidity under a 12-h light–dark cycle (lights at 08.00). Animals
were housed in a licensed biomedical facility (RCSI Department
of Surgery, Beaumont Hospital) and all procedures were carried
out under animal license guidelines of the Ministry of Health,
Ireland. Animals had ad libitum access to animal chow (WM
Connolly & Sons Ltd, Kilkenny, Ireland) and water.
Cell culture and injection of cells
The spontaneously metastasizing mammary adenocarcinoma cell
line, 4T1, was generously provided by Mr E Coveny (Waterford
Regional Hospital, County Waterford, Ireland). All cell culture
reagents were obtained from Gibco-BRL (Paisley, UK). 4T1 cells
were maintained in RPMI-1640 supplemented with 10% heat-
inactivated fetal calf serum (FCS), 100 U ml–1 penicillin and
100 mg ml–1 streptomycin sulphate in a humidified atmosphere of
5% CO2 in air at 37°C. Cells at 80% confluency were removed
by trypsinization and washed three times in Ca++/Mg++-free
phosphate-buffered saline (PBS). Cells were resuspended at
5  ´ 105 ml–1 in PBS and 200 ml injected into each mouse via the
lateral tail vein following intramuscular administration of the anaes-
thetic and vasodilator hypnorm (Janssen, Buckinghamshire, UK).
Experimental design – surgical groups
Two weeks after tumour cell injection, mice were randomized into
four groups (n = 8 per group). A control group received anaes-
thesia (Halothane, Rhone-Poulenc Rorer Ltd, Dublin, Ireland) for
30 min, a laparoscopy group received air sufflation of the peri-
toneal cavity for a period of 30 min, a group received laparoscopy
with CO2 instead of air (3 mmHg constant pressure) and a laparo-
tomy group underwent a midline incision along the peritoneum
with periodical agitation of the intestines over a 30-min time
interval.
Five days later, the animals were weighed, blood was collected
and animals sacrificed by cervical dislocation. Lungs were excised
and weighed immediately. The percentage lung weight: body
weight (lung weight/body weight ´ 100) was used as an indicator
of metastatic burden, similar to the method used previously to
assess kidney hypertrophy (Nakamura et al, 1996). The lungs were
fixed in 10% formalin and processed for histology.
Experimental design – injection groups
In a second set of experiments, animals received tumour cells via
the lateral tail vein as before. Two weeks later the animals were
divided into two groups (n = 8 per group). The control group
received a 200 ml intraperitoneal (i.p.) injection of sterile saline
and the experimental group received a 200 ml injection of
50 mg ml–1 commercial LPS (Sigma Corp., Dublin, Ireland) in
saline, i.e. 10 mg LPS per mouse. Parameters were measured as
for the surgical groups.
Serum collection
Mice were anaesthetized with halothane and their chests cleaned
with ethanol. Blood was obtained via closed cardiac puncture by
means of a 22-gauge hypodermic needle and a subxiphoid
approach. Blood was allowed to clot for 2 h at room temperature
and centrifuged for 20 min at 1100 g. Serum was removed, filtered
through a 0.22-mm filter and stored at –80°C. VEGF was measured
by enzyme-linked immunosorbent assay (ELISA) according to
manufacturer’s instructions (R&D Systems, Oxford, UK).
Histology
Paraffin-embedded sections were stained with haematoxylin and
eosin and a mitotic index (MI) estimated using a 1 mm3 grid
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Figure 1 Metastatic burden in mice following surgery. Surgery was
performed 2 weeks after tail vein injection of 105 4T1 mammary cells. Five
days later animals were sacrificed and lungs were removed. Tumour burden
is expressed as lung weight/body weight ´ 100 (mean ± s.d., n = 8 per
group). A significant increase in metastatic growth was observed following
laparotomy and air laparoscopy *(P < 0.0001) compared to controls or CO2
laparoscopy #(P < 0.001)counting an average of 500 tumour cells mm–3. Ten fields were
scored by two independent observers (GP and JH) in a blinded
fashion. Mitotic cells were identified morphologically and the
mean number of mitotic cells in ten fields used as the mitotic
index.
Apoptotic cells were stained using the in situ cell death detec-
tion kit according to manufacturer’s instructions (Boehringer
Mannheim, East Sussex, UK). Peroxidase activity was visualized
by the precipitation of 3,3´-diaminobenzidene. Apoptotic cells
stained brown and were counted as above. The apoptotic index
(AI) was calculated as the mean number of positively stained cells
in ten fields.
VEGF production by 4T1 cells in vitro
4T1 tumour cells were plated at 2 ´ 104 cells well–1 in 96-well
plates. Sixteen hours later LPS (0–10 mg ml–1) was added.
Eighteen hours later supernatants were collected and stored at
–80°C for analysis. Cells were washed twice with PBS and total
protein measured using the Bicinchoninic Acid method (Pierce,
IL, USA). Supernatants were assayed for VEGF by ELISA (R&D
Systems, Oxford, UK) and results expressed as VEGF pg mg–1 total
protein.
Plasma LPS measurement
Animals (n = 5) were inoculated with 4T1 tumour cells as before,
and randomly divided into surgical and injection groups as previ-
ously described in the experimental design section. Four hours
after surgical treatment or injection, blood was harvested via
closed cardiac puncture into pyrogen-free Coatex Endo tubes
(Chromogenix AB, Mölndak, Sweden) and plasma separated
by centrifugation at 2200 g for 15 min. Plasma LPS levels
were measured using the Limulus Amebocyte Lysate assay
(Chromogenix AB, Mölndak, Sweden) according to manufac-
turer’s protocol and results expressed as LPS EU ml–1.
Statistical analysis
Statistical comparison between surgical groups was carried out
with analysis of variance (ANOVA) and Scheffe post-hoc correc-
tion using DataDesk 4.1TM (Data Description Inc., Ithaca, NY, US).
The two injection groups were analysed using a two-sample t-test
in DataDesk 4.1TM. Results are expressed as means ± standard
deviation (s.d.). Data were taken as significant where P < 0.05. A
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Figure 2 Mitosis and apoptosis within lung metastases following surgery.
(A) Mitotic cells in lung metastases. Arrow indicates cell during anaphase
with chromosome separation to two separate poles (magnification 3 400).
(B) Apoptotic cells in lung metastases. Arrow indicates apoptotic cell
following TUNEL staining as described in Materials and Methods
(magnification 3 400). (C) Mitosis: apoptosis ratios within metastases
following surgery. The number of mitotic and apoptotic cells (mean of ten
fields) were estimated for each group and the ratio calculated. Data
represent mean ± s.d. (n = 8 per group). A significant increase in
mitosis:apoptosis ratios were observed following laparotomy and air
laparoscopy *(P < 0.01) compared to controls or CO2 laparoscopy. There
was no significant difference between the controls and CO2 laparoscopy
groups (P = NS)
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VEGF levels in relation to plasma LPS concentrations.
RESULTS
Effect of surgery on metastatic tumour growth
4T1 mammary adenocarcinoma cells spontaneously metastasize to
the lungs. A preliminary study established that lung metastases
were visibly present 14 days after tail vein injection of 105 4T1
tumour cells. No metastases were apparent in other organs at this
time or at the time of sacrifice (5 days later). There was no signifi-
cant difference in body weights between groups, indicating that
the animals were not cachectic (P = not significant (NS)) and no
apparent oedema was observed. Both laparotomy (3.37 ± 0.14)
and air laparoscopy (2.73 ± 0.11) groups had a significantly
(P < 0.0001) higher metastatic burden than controls (1.32 ± 0.12),
indicated by lung/body weight measurements. A metastatic burden
similar to controls was observed in animals undergoing CO2
laparoscopy, where air is excluded (1.94 ± 0.42,  P = NS)
(Figure 1). Surface examination of the lungs in the laparotomy and
air laparoscopy groups revealed multiple macroscopic tumour
metastases in comparison with the other two groups.
We assessed tumour cell mitosis and apoptosis within lung
metastases. Similar trends were observed to those seen for the
metastatic burden. Representative sections with highlighted
mitotic and apoptotic cells are shown in Figure 2A and 2B,
respectively. The laparotomy (8.33 ± 0.21) and air laparoscopy
(7.99 ± 0.09) groups had significantly (P < 0.0001) higher mitotic
indices compared with control (4.39 ± 0.63) or CO2 laparoscopy
(4.71 ± 0.15) groups. Laparotomy (1.31 ± 0.13) and laparoscopy
with air (1.33 ± 0.42) resulted in significantly (P < 0.01) lower
apoptotic indices compared with controls (4.46 ± 1.13). In con-
trast, laparoscopy with CO2 resulted in a similar mitotic
(4.39  ± 0.63) and apoptotic index to controls (3.17 ± 0.76,
P = NS).
As net tumour growth is ultimately determined by the relative
numbers of proliferating and apoptotic tumour cells, the ratio of
MI/AI was calculated as described. Laparotomy (6.20 ± 0.35) and
laparoscopy with air (6.35 ± 1.00) resulted in significantly
(P < 0.01) higher ratios compared with either CO2 laparoscopy
(1.54 ± 0.19) or control (1.02 ± 0.15) groups (Figure 2C).
Plasma LPS levels following surgery
Laparotomy (1.22 ± 0.18 EU ml–1) and air laparoscopy
(0.50  ± 0.15 EU ml–1) groups had significantly (P < 0.05) higher
levels of circulating LPS than control (0.13 ± 0.09 EU ml–1).
Animals that received laparoscopy with air excluded (CO2
laparoscopy) had levels of LPS comparable with controls (0.19 ±
0.14 EU ml–1, P = NS versus control) (Figure 3).
Effect of LPS injection on metastatic tumour growth
Endotoxin injection resulted in a significantly (P < 0.001) higher
metastatic burden compared with the group receiving the saline
injection (2.84 ± 0.20 vs 1.99 ± 0.10 respectively) (Figure 4A).
Endotoxin injection resulted in a similar metastatic burden to that
observed (Figure 1) in the laparotomy and air laparoscopy groups
(3.37 ± 0.14 and 2.73 ± 0.11 respectively). This higher metastatic
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Figure 3 Plasma LPS levels following surgery. Blood was collected by
cardiac puncture and LPS levels were examined 4 h post-surgery by the LAL
assay as described in Materials and Methods. Data represent mean ± s.d.
(n = 8 per group). Laparotomy t (P < 0.0001) and air laparoscopy j
(P < 0.03) both resulted in significantly elevated levels of circulating LPS
compared to the controls receiving anesthesia alone. No significant
difference was observed between the control and CO2 laparoscopy groups
(P = NS)
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Figure 4 (A) Lung:body weight in mice following saline or LPS injection.
Two weeks after tail vein injection of 105 4T1 mammary cells animals
received an injection of saline or 10 mg LPS. Five days later animals were
sacrificed and lungs were removed. Data represent mean ± s.d. (n = 5 per
group). A significantly higher tumour burden (indicated by lung/body weights)
was observed following LPS injection *(P < 0.0002) compared to animals
receiving an equivalent injection of saline. (B) Mitosis:apoptosis ratios within
lung metastases of mice following saline or LPS injection. Data represent
mean ± s.d. (n = 5 per group). A significantly higher * (P < 0.02) ratio was
observed following LPS injection compared to animals receiving saline
injectionburden was accompanied by a higher mitotic index in the endo-
toxin injection group (7.68 ± 0.42) compared with the saline injec-
tion group (4.74 ± 1.71). In addition, a lower apoptotic index was
observed in the endotoxin group (1.27 ± 0.19) compared with the
saline group (2.98 ± 0.91). The MI/AI ratio in the endotoxin
injection group (6.18 ± 0.64) was significantly (P < 0.02) higher
than the ratio observed following saline injection (2.02 ± 0.88)
(Figure 4B) and similar to the MI/AI ratio in the surgical groups
exposed to air – laparotomy (6.20 ± 0.35) and laparoscopy with
air sufflation (6.35 ± 1.00).
Serum VEGF levels following surgery or injection
Laparotomy (77.92 ± 5.00 pg ml–1) and air laparoscopy
(61.97  ± 7.14 pg ml–1) resulted in significantly (P < 0.0001)
elevated post-operative levels of circulating VEGF compared with
either control (14.28 ± 5.44 pg ml–1) or CO2 laparoscopy groups
(28.41 ± 13.70 pg ml–1) (Figure 5A). No significant difference
was observed between the control and CO2 laparoscopy group
(P = NS). The presence of high levels of this pro-angiogenic factor
in the circulation following surgery implicates an angiogenic
mechanism in the enhanced tumour growth observed in the
surgical groups exposed to air and in animals receiving endotoxin
injection (207.85 ± 42.74 pg ml–1).
Endotoxin injection resulted in significantly (P < 0.003) higher
levels of serum VEGF than saline injection (33.88 ± 7.34 pg ml–1)
(Figure 5B). This level is almost threefold that observed in animals
undergoing laparotomy. This may be due to the high levels of
circulating LPS following i.p. injection of 10mg LPS (3.13 ± 0.14
EU ml–1), which was also threefold higher than plasma LPS in the
laparotomy group (1.22 ± 0.18 EU ml–1). A strong positive signifi-
cant correlation (r = 0.966) was observed between circulating
VEGF and LPS levels, when all groups were examined in parallel
(Figure 6). Therefore we investigated the effect of LPS on VEGF
production by 4T1 tumour cells in vitro.
Tumour cell production of VEGF following LPS
stimulation
LPS treatment (10 ng, 100 ng, 1 mg and 10 mg) directly
up-regulated VEGF production by 4T1 tumour cells in vitro
(93.27  ± 18.14, 95.94 ± 19.83, 100.30 ± 16.07 and 117.22 ± 23.78
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Figure 5 (A) Serum VEGF in mice following surgery. Five days post-operatively blood was obtained by cardiac puncture and VEGF was assessed by
quantitative ELISA. Data represent mean ± s.e.m. (n = 8 per group). A significant increase in circulating levels of VEGF was observed following laparotomy and
laparoscopy with air compared to controls * (P < 0.0001) or CO2 laparoscopy groups, j (P < 0.01) t (P < 0.001). (B) Serum VEGF levels following i.p. injection
of saline or 10 mg LPS. Data represent mean ± s.d. (n = 5 per group). LPS injection resulted in a significant* (P < 0.0003) increase in circulating levels of VEGF
compared to animals receiving a saline injection
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Figure 6 Circulating VEGF in relation to plasma LPS levels (n = 24). A
strong positive correlation (r = 0.966) was observed between serum VEGF
and plasma LPS levels
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Figure 7 VEGF production by 4T1 tumour cells following stimulation with
LPS. 2 3 104 4T1 cells were plated out in 96-well plates, and 18 h later they
were incubated with different concentrations of LPS. LPS at concentrations
above 10 ng ml–1 resulted in significantly * (P < 0.05) higher levels of VEGF
(pg mg–1 total cell protein). Data represent mean ± s.d. of three experiments
carried out in duplicatepg mg–1 protein respectively, P < 0.02 vs untreated control cells
59.10 ± 3.73 pg mg–1 protein) (Figure 7).
DISCUSSION
We identified increased metastatic tumour growth in mice which
underwent laparotomy or air laparoscopy, where the peritoneum
was insufflated with air, compared to controls which received
anaesthetic only. Mice that received a CO2 laparoscopy, where air
is excluded, had a metastatic burden comparable to the control
group, implicating an airborne factor in this increased metastatic
growth. The increases in metastatic burden coincided with signifi-
cantly higher tumour cell mitosis and lower apoptosis within lung
metastases of both laparotomy and air laparoscopy groups. The
removal of a primary tumour (and consequently the anti-angio-
genic factors it produces) has been implicated in post-operative
tumour recurrence (O’Reilly et al, 1994, 1997). In our model there
is no primary tumour established. Therefore, the increased
metastatic growth observed in animals exposed to air during the
surgical procedure cannot be attributed to the removal of anti-
angiogenic factors. The tumour enhancing effect of open surgery
has been demonstrated previously (Skipper et al, 1989; Arai et al,
1992; Kodama et al, 1992), but the mechanisms by which surgery
increases tumour growth have remained unclear.
Both laparotomy and air contamination of the peritoneum have
previously been shown to result in bacterial translocation across
the gut (Watson et al, 1995), and we observed high plasma levels
of LPS in animals 4 h after i.p injection of LPS. Bacterial translo-
cation results in the release of LPS from endogenous gut bacteria,
potentiating the inflammatory response. Our study suggests that
air contamination during the surgical procedure is one of the
stimuli responsible for the enhanced tumour growth and angiogen-
esis observed following open surgery. In animals which received
endotoxin injection, metastatic burden was increased compared to
those receiving a saline injection. Again, this increase was
reflected in higher tumour cell proliferation and decreased apop-
tosis within the lung metastases. LPS has been implicated in
cellular proliferation and differentiation, possibly through the
phosphorylation and activation of several protein kinases
(Weinstein et al, 1992; Shapira et al, 1994).
VEGF is the most potent angiogenic factor known (Peters et al,
1993). VEGF production can be regulated by a range of effector
molecules and cytokines. Open surgery and air laparoscopy
resulted in significantly elevated levels of circulating serum VEGF
compared with either the CO2 laparoscopy group or controls.
Animals receiving an endotoxin injection also had elevated serum
VEGF indicating that, in addition to promoting tumour growth,
LPS induces the release of the pro-angiogenic cytokine VEGF.
When the levels of plasma LPS were compared with circulating
VEGF in all groups, a strong positive correlation was observed
and we demonstrated that LPS directly increased VEGF produc-
tion by tumour cells in vitro.
Our results indicate that endotoxin, introduced into the circula-
tion during the surgical procedure, augments metastatic growth by
increasing tumour cell proliferation, decreasing tumour cell apop-
tosis and increasing production of the angiogenic factor VEGF. It
is therefore likely that endotoxin plays a role in tumour recurrence
following surgical trauma. Thus, increased metastatic tumour
growth following removal of a primary tumour may not be entirely
due to the removal of angiogenesis inhibitors produced by the
primary tumour. Our findings may be of particular relevance to
patients with a previous history of cancer undergoing surgery for
an unrelated complaint. We are currently investigating whether the
administration of blocking antibodies to LPS in the peri-operative
period attenuates surgically induced increases in metastatic
tumour growth.
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